期刊文献+

鼻咽癌组织端粒酶各组分基因表达的研究 被引量:4

Expression of Telomerase Subunits in Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的:探讨端粒酶各组分基因在鼻咽癌( nasopharyngeal carcinoma,NPC)组织及鼻咽慢性炎症粘膜( chronic inflammation of nasopharyngeal epithelium,CINE)组织中的表达情况。方法:利用 RT-PCR方法检测鼻咽癌组织及鼻咽慢性炎症粘膜组织端粒酶各组分基因( hTR、 TP1 mRNA和 hTERT mRNA)的表达。结果: 43例 NPC组织中, hTR、 TP1 mRNA和 hTERT mRNA表达阳性率分别为 90.7%、 88.4%和 88.4%; 16例 CINE组织中 ,hTR、 TP1 mRNA和 hTERT mRNA表达阳性率为 87.5%、 87.5%和 0%;仅 hTERT mRNA在鼻咽癌组织中的表达显著高于鼻咽慢性炎症粘膜组织中的表达,而 hTR或 TP1 mRNA在鼻咽癌组织中的表达和鼻咽慢性炎症粘膜组织中的表达无明显差异。表明 hTR和 TP1 mRNA广泛存在于鼻咽癌和鼻咽慢性炎症粘膜组织中,而 hTERT mRNA仅在鼻咽癌组织中表达。结论: hTERT mRNA可能在端粒酶活性调节中起重要作用; hTERT mRNA的表达水平,可作为鼻咽癌诊断指标之一。 Objective: This study was designed to ascertain telomerase subunits expression in nasopharyngeal carcinoma (NPC) as well as in chronic inflammation of nasopharyngeal epithelium (CINE). Methods: Telomerase subunits(hTR,TP1 mRNA, hTERT mRNA) expression was determined with reverse transcription-polymerase chain reaction (RT-PCR) in 43 cases of NPC and 16 cases of CINE. Results: The positive rates of hTR,TP1 mRNA and hTERT mRNA were 90.7% ,88% , and 88% in 43 NPCs, and 87.5% , 87.5% , and 0 in 16 CINEs respectively. hTERT mRNA exoressuib was significantly higher in NPC than in CINE,but no statistical difference for hTR or TP1 mRNA occurred in two groups of patients. Conclusion: These findings revealed that hTR and TP1 mRNA were widely expressed in both NPC and CINE, but hTERT mRNA was limited in NPC, which suggests that hTERT mRNA may play a critical role in activation of telomerase. The authers findings also indicate that detection of hTERT mRNA may be a useful maker for clinical diagnosis of NPC.
出处 《癌症》 SCIE CAS CSCD 北大核心 2001年第3期245-248,共4页 Chinese Journal of Cancer
关键词 鼻咽肿瘤 端粒酶 端粒酶亚单位 基因表达 HTERT MRNA : Nasopharyngeal carcinoma Telomerase Telomerase subunits
  • 相关文献

参考文献3

二级参考文献9

  • 1Rhyu MS.Telomeres.Telomerase and Immortality.J Natl Cancer Inst,1995,87:884-894.
  • 2Cheng RYS.Yuen PW.Nicholls JM,et al.Telomerase activation in nasopharyngeal carcinomas.British J of Cancer,1998,77(3):456-460.
  • 3Bednarek A,Budunova I,Slaga TJ,et al.Increased telomerase activity in mouse skin premalignant progression.Cancer Res,1995,55:4566-4569.
  • 4Klingelhutz AJ,Foster SA,Mcolougall JK.Telomerase activation by the E6 gene product of human papilloma virus type 16. Nature,1996,380(6569):79-82.
  • 5Hiyama E,Yokoyama T,Tatsumoto N,et al.Telomerase activity in gastric.Cancer Res,1995,55:3258-3262.
  • 6Hiyama E,Gollabon L,Kataoka T,et al.Telomerase activity in human breast tumors.J Natl Cancer Inst,1996,88:116-22.
  • 7Wright WE,Piatyszek MA,Shay JW,et al.Experimental elongation of telomeres extends the lifespan immortal x normal cell hybrid.EMBOJ,1996,15:1734.
  • 8Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancer.Science,1994,266(23):2011-2015.
  • 9彭剑雄,陈正炎,李志坚,罗建新,伍勇,刘连红.急性白血病端粒酶的表达[J].湖南医科大学学报,1998,23(3):289-291. 被引量:10

共引文献12

同被引文献28

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部